Developing Recombinant GDF11 to Promote Healthy Vasculature and Treat Age-Related Diseases with Dr. Mark Allen Elevian TRANSCRIPT

https://traffic.libsyn.com/secure/empoweredpatient/Empowered_Patient_Podcast_Mark_Allen_Elevian_TRANSCRIPT.pdf?dest-id=291449

Dr. Mark Allen, Co-Founder and CEO, Elevian is looking to disrupt the longevity business by developing a recombinant GDF11 to treat and prevent multiple age-related diseases. The first application being investigated is for stroke recovery drawing on the discovery that GDF11 decreases with age and when replenished, returns the brain to a healthier pattern of vascularization. Not looking to extend just the life span, the goal is to target the aging process and extend the healthy lifespan.

@ElevianInc #aging #StrokeRecovery #AgeRelatedDisease #GDF11

Elevian.com

Listen to the podcast here.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Related Post

NEWSLETTER

Sign up for Breaking News, Newsletter, Blog Posts and Special Deals from 1631 Digital and their media/marketing partners.

Subscribers agree to be contacted from 1631 Digital News and/or their media/marketing partners for breaking news alerts, newsletters and special media marketing offers via email, mail and/or texting communication.